175
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Statistical optimization of insulin-loaded Pluronic F-127 gels for buccal delivery of basal insulin

, &
Pages 363-374 | Received 20 Oct 2010, Accepted 09 Nov 2010, Published online: 10 Jan 2011

References

  • Fonseca V. The role of basal insulin therapy in patients with type 2 diabetes mellitus. Insulin 2006;1(2):51–60.
  • Ghilzai NMK. New developments in insulin delivery. Drug Dev Ind Pharm 2003;29(3):253–265.
  • Wang W. Instability, stabilization and formulation of liquid protein pharmaceutical. Int J Pharm 1999;185:129–188.
  • Nielson L, Khurana R, Coats A, Frokjaer S, Brange J, Vyas S, Uversky VN, Fink AL. Effect of environmental factors on the kinetics of insulin fibril formation: Elucidation of the molecular mechanism. Biochemistry 2001;40:6036–6046.
  • Morishita M, Barichello JM, Takayama K, Chiba Y, Tokiwa S, Nagai T. Pluronic F-127 gels incorporating highly purified unsaturated fatty acids for buccal delivery of insulin. Int J Pharm 2001;212:289–293.
  • Jeong B, Kim SW, Bae YH. Thermosentive sol-gel reversible hydrogels. Adv Drug Del Rev 2002;54:37–51.
  • Gariepey EV, Leroux JC. In situ-forming hydrogels – review of temperature-sensitive systems. Eur J Pharm Biopharm 2004;58:409–426.
  • Bhardwaj R, Blanchard J. Controlled-release delivery system for the α-MSH Analog Melanotan-1 using Poloxamer 407. J Pharm Sci 1996;85(9):915–919.
  • Desai SD, Blanchard J. In vitro evaluation of Pluronic F127-based controlled-release ocular delivery systems for pilocarpine. J Pharm Sci 1998;87(2):226–230.
  • Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm 2000;203:1–60.
  • Stratton LP, Dong A, Manning MC, Carpenter JF. Drug delivery matrix containing native protein precipitates suspended in a Poloxamer gel. J Pharm Sci 1997;86(9):1006–1010.
  • Das N, Madan P, Lin S. Development and in vitro evaluation of insulin-loaded buccal Pluronic F-127 gels. Pharm Devel Tech 2010;15:192–208.
  • Najafabadi AR, Moslemi P, Tajerzadeh H. Intranasal bioavailability of insulin from Carbopol-based gel spray in rabbits. Drug Del 2002;11:295–300.
  • Schmolka IR. Artificial skin I. Preparation and properties of Pluronic F-127 gels for treatment of burns. J Biomed Mater Res 1972;6:571–582.
  • Wagner JG, Nelson E. Percent absorbed time plots derived from blood level and/or urinary excretion data. J Pharm Sci 1963;52:610–611.
  • Katz AI, Rubenstein AH. Metabolism of proinsulin, insulin, and c-peptide in the rat. J Clin Invest 1973;52:1113–1121.
  • Schmolka IR. Polymers for controlled drug delivery. 1st ed. Boca Raton, FL: CRC Press, 1984:189–214.
  • Zhang L, Parsons DL, Navarre C, Kompella UB. Development and in-vitro evaluation of sustained release Poloxamer 407 (P407) gel formulations of ceftiofur. J Control Rel 2002;85:73–81.
  • Pandit NK, Wang D. Salt effects on the diffusion and release rate of propranolol from Poloxamer 407 gels. Int J Pharm 1998;167:183–189.
  • Pandit NK, Kisaka J. Loss of gelation ability of Pluronic F127 in the presence of some salts. Int J Pharm 1996;145:129–136.
  • Guzman M, Garcia FF, Molpeceres J, Aberturas J. Polyoxyethylene-polyoxypropylene block copolymer gels as sustained release vehicles for subcutaneous drug administration. Int J Pharm 1992;80:119–127.
  • Choi HG, Jung JH, Ryu JM, Yoon SJ, Oh YK, Kim CK. Development of in situ gelling and mucoadhesive acetaminophen liquid suppository. Int J Pharm 1998;165:33–44.
  • Hamid SMA, Hady SEA, Shamy AAE, Dessouky HFE. Formulation of an antispasmodic drug as a topical local anesthetic. Int J Pharm 2006; 326:107–118.
  • Miller SC, Drabik BR. The rheological properties of poloxamer vehicle. Int J Pharm 1984;18:269–276.
  • Goddard ED, Ananthapadmanabhan KP. Interaction of surfactants with polymers and proteins. Boca Raton, FL: CRC Press; 1993:171–202.
  • August BJ, Rogers NJ, Shefter E. Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter. Pharmacol Exp Ther 1988;244(1):23–27.
  • Canaba A, Ait-Kadi A, Juhasz J. Study of the gelation process of polyethylene oxide-polypropylene oxide, polyethylene oxide copolymer (Poloxamer 407) aqueous solution. J Coll Interf Sci 1997;190:307–312.
  • Ricci EJ, Lunardi LO, Nanclares DMA, Marchetti JM. Sustained release of lidocaine from Poloxamer 407 gels. Int J Pharm 2005;288:235–244.
  • Pandit N, Trygstad T, Croy S, Bohorquez M, Koch C. Effect of salt on the micellization, clouding and solubilization behavior of Pluronic F127 solutions. J Coll Interf Surf 2000;222:213–220.
  • Vadnere M, Amidon G, Lindenbaum S, Haslam J. Thermodynamic studies on the gel-sol transition of some Pluronic polyols. Int J Pharm 1984;22:207–218.
  • Jones DS, Woofson AD, Brown AF, Coulter WA, McClelland C, Irwin CR. Design, characterization and preliminary clinical evaluation of a novel mucoadhesive topical formulation containing tetracycline for the treatment of periodontal disease. J Control Rel 2000;67:357–368.
  • El-Kamel AH. In vitro and in vivo evaluation of Pluronic F127 based ocular delivery system for timolol maleate. J Control Rel 2002;241:47–55.
  • Gurny R, Meyer JM, Peppas NA. Bioadhesive intraoral release systems: Design, testing and analysis. Biomat 1984;5:336–340.
  • Volkin DB, Klibanov AM. Minimizing protein inactivation. In: Creighton TE, editor. Protein function: A Practical Approach. Oxford, UK: Information Press, 1989:1–24.
  • Timasheff SN. Control of protein stability and reactions by weakly interacting cosolvents: The simplicity of the complicated. Adv Protein Chem 1998; 51:355–432.
  • Katakam M, Banga AK. Use of poloxamer polymers to stabilize remonbinant human growth hormone against various processing stresses. Pharm Dev Technol 1997;2:143–149.
  • Wang PL, Johnston TP. Enhanced stability of two model proteins in an agitated solution environment using Poloxamer 407. J Parenter Sci Technol 1993;47:183–189.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.